Global and United States Regenerative Medicine Market Size, Status and Forecast 2021-2027
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Application
1.3.1 Global Regenerative Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Medicine Market Perspective (2016-2027)
2.2 Regenerative Medicine Growth Trends by Regions
2.2.1 Regenerative Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Regenerative Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Regenerative Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Regenerative Medicine Industry Dynamic
2.3.1 Regenerative Medicine Market Trends
2.3.2 Regenerative Medicine Market Drivers
2.3.3 Regenerative Medicine Market Challenges
2.3.4 Regenerative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Medicine Players by Revenue
3.1.1 Global Top Regenerative Medicine Players by Revenue (2016-2021)
3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Regenerative Medicine Revenue
3.4 Global Regenerative Medicine Market Concentration Ratio
3.4.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2020
3.5 Regenerative Medicine Key Players Head office and Area Served
3.6 Key Players Regenerative Medicine Product Solution and Service
3.7 Date of Enter into Regenerative Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Medicine Breakdown Data by Type
4.1 Global Regenerative Medicine Historic Market Size by Type (2016-2021)
4.2 Global Regenerative Medicine Forecasted Market Size by Type (2022-2027)
5 Regenerative Medicine Breakdown Data by Application
5.1 Global Regenerative Medicine Historic Market Size by Application (2016-2021)
5.2 Global Regenerative Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Regenerative Medicine Market Size (2016-2027)
6.2 North America Regenerative Medicine Market Size by Type
6.2.1 North America Regenerative Medicine Market Size by Type (2016-2021)
6.2.2 North America Regenerative Medicine Market Size by Type (2022-2027)
6.2.3 North America Regenerative Medicine Market Size by Type (2016-2027)
6.3 North America Regenerative Medicine Market Size by Application
6.3.1 North America Regenerative Medicine Market Size by Application (2016-2021)
6.3.2 North America Regenerative Medicine Market Size by Application (2022-2027)
6.3.3 North America Regenerative Medicine Market Size by Application (2016-2027)
6.4 North America Regenerative Medicine Market Size by Country
6.4.1 North America Regenerative Medicine Market Size by Country (2016-2021)
6.4.2 North America Regenerative Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Regenerative Medicine Market Size (2016-2027)
7.2 Europe Regenerative Medicine Market Size by Type
7.2.1 Europe Regenerative Medicine Market Size by Type (2016-2021)
7.2.2 Europe Regenerative Medicine Market Size by Type (2022-2027)
7.2.3 Europe Regenerative Medicine Market Size by Type (2016-2027)
7.3 Europe Regenerative Medicine Market Size by Application
7.3.1 Europe Regenerative Medicine Market Size by Application (2016-2021)
7.3.2 Europe Regenerative Medicine Market Size by Application (2022-2027)
7.3.3 Europe Regenerative Medicine Market Size by Application (2016-2027)
7.4 Europe Regenerative Medicine Market Size by Country
7.4.1 Europe Regenerative Medicine Market Size by Country (2016-2021)
7.4.2 Europe Regenerative Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Medicine Market Size (2016-2027)
8.2 Asia-Pacific Regenerative Medicine Market Size by Type
8.2.1 Asia-Pacific Regenerative Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Regenerative Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Regenerative Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Regenerative Medicine Market Size by Application
8.3.1 Asia-Pacific Regenerative Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Regenerative Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Regenerative Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Regenerative Medicine Market Size by Region
8.4.1 Asia-Pacific Regenerative Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Regenerative Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Regenerative Medicine Market Size (2016-2027)
9.2 Latin America Regenerative Medicine Market Size by Type
9.2.1 Latin America Regenerative Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Regenerative Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Regenerative Medicine Market Size by Type (2016-2027)
9.3 Latin America Regenerative Medicine Market Size by Application
9.3.1 Latin America Regenerative Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Regenerative Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Regenerative Medicine Market Size by Application (2016-2027)
9.4 Latin America Regenerative Medicine Market Size by Country
9.4.1 Latin America Regenerative Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Regenerative Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Medicine Market Size (2016-2027)
10.2 Middle East & Africa Regenerative Medicine Market Size by Type
10.2.1 Middle East & Africa Regenerative Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Regenerative Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Regenerative Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Regenerative Medicine Market Size by Application
10.3.1 Middle East & Africa Regenerative Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Regenerative Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Regenerative Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Regenerative Medicine Market Size by Country
10.4.1 Middle East & Africa Regenerative Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Regenerative Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 J & J (DePuy Synthes)
11.1.1 J & J (DePuy Synthes) Company Details
11.1.2 J & J (DePuy Synthes) Business Overview
11.1.3 J & J (DePuy Synthes) Regenerative Medicine Introduction
11.1.4 J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2016-2021)
11.1.5 J & J (DePuy Synthes) Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Regenerative Medicine Introduction
11.2.4 Medtronic Revenue in Regenerative Medicine Business (2016-2021)
11.2.5 Medtronic Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Regenerative Medicine Introduction
11.3.4 Zimmer Biomet Revenue in Regenerative Medicine Business (2016-2021)
11.3.5 Zimmer Biomet Recent Development
11.4 Stryker
11.4.1 Stryker Company Details
11.4.2 Stryker Business Overview
11.4.3 Stryker Regenerative Medicine Introduction
11.4.4 Stryker Revenue in Regenerative Medicine Business (2016-2021)
11.4.5 Stryker Recent Development
11.5 Allergan(Acelity)
11.5.1 Allergan(Acelity) Company Details
11.5.2 Allergan(Acelity) Business Overview
11.5.3 Allergan(Acelity) Regenerative Medicine Introduction
11.5.4 Allergan(Acelity) Revenue in Regenerative Medicine Business (2016-2021)
11.5.5 Allergan(Acelity) Recent Development
11.6 MiMedx Group
11.6.1 MiMedx Group Company Details
11.6.2 MiMedx Group Business Overview
11.6.3 MiMedx Group Regenerative Medicine Introduction
11.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2016-2021)
11.6.5 MiMedx Group Recent Development
11.7 Organogenesis
11.7.1 Organogenesis Company Details
11.7.2 Organogenesis Business Overview
11.7.3 Organogenesis Regenerative Medicine Introduction
11.7.4 Organogenesis Revenue in Regenerative Medicine Business (2016-2021)
11.7.5 Organogenesis Recent Development
11.8 Fujifilm Cellular Dynamics
11.8.1 Fujifilm Cellular Dynamics Company Details
11.8.2 Fujifilm Cellular Dynamics Business Overview
11.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Introduction
11.8.4 Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2016-2021)
11.8.5 Fujifilm Cellular Dynamics Recent Development
11.9 Osiris Therapeutics
11.9.1 Osiris Therapeutics Company Details
11.9.2 Osiris Therapeutics Business Overview
11.9.3 Osiris Therapeutics Regenerative Medicine Introduction
11.9.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2016-2021)
11.9.5 Osiris Therapeutics Recent Development
11.10 Vcanbio
11.10.1 Vcanbio Company Details
11.10.2 Vcanbio Business Overview
11.10.3 Vcanbio Regenerative Medicine Introduction
11.10.4 Vcanbio Revenue in Regenerative Medicine Business (2016-2021)
11.10.5 Vcanbio Recent Development
11.11 CCBC
11.11.1 CCBC Company Details
11.11.2 CCBC Business Overview
11.11.3 CCBC Regenerative Medicine Introduction
11.11.4 CCBC Revenue in Regenerative Medicine Business (2016-2021)
11.11.5 CCBC Recent Development
11.12 Cytori
11.12.1 Cytori Company Details
11.12.2 Cytori Business Overview
11.12.3 Cytori Regenerative Medicine Introduction
11.12.4 Cytori Revenue in Regenerative Medicine Business (2016-2021)
11.12.5 Cytori Recent Development
11.13 Celgene
11.13.1 Celgene Company Details
11.13.2 Celgene Business Overview
11.13.3 Celgene Regenerative Medicine Introduction
11.13.4 Celgene Revenue in Regenerative Medicine Business (2016-2021)
11.13.5 Celgene Recent Development
11.14 Vericel Corporation
11.14.1 Vericel Corporation Company Details
11.14.2 Vericel Corporation Business Overview
11.14.3 Vericel Corporation Regenerative Medicine Introduction
11.14.4 Vericel Corporation Revenue in Regenerative Medicine Business (2016-2021)
11.14.5 Vericel Corporation Recent Development
11.15 Guanhao Biotech
11.15.1 Guanhao Biotech Company Details
11.15.2 Guanhao Biotech Business Overview
11.15.3 Guanhao Biotech Regenerative Medicine Introduction
11.15.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2016-2021)
11.15.5 Guanhao Biotech Recent Development
11.16 Mesoblast
11.16.1 Mesoblast Company Details
11.16.2 Mesoblast Business Overview
11.16.3 Mesoblast Regenerative Medicine Introduction
11.16.4 Mesoblast Revenue in Regenerative Medicine Business (2016-2021)
11.16.5 Mesoblast Recent Development
11.17 AMAG Pharmaceuticals (CBR)
11.17.1 AMAG Pharmaceuticals (CBR) Company Details
11.17.2 AMAG Pharmaceuticals (CBR) Business Overview
11.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Introduction
11.17.4 AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2016-2021)
11.17.5 AMAG Pharmaceuticals (CBR) Recent Development
11.18 ViaCord
11.18.1 ViaCord Company Details
11.18.2 ViaCord Business Overview
11.18.3 ViaCord Regenerative Medicine Introduction
11.18.4 ViaCord Revenue in Regenerative Medicine Business (2016-2021)
11.18.5 ViaCord Recent Development
11.18 CordLife
.1 CordLife Company Details
.2 CordLife Business Overview
.3 CordLife Regenerative Medicine Introduction
.4 CordLife Revenue in Regenerative Medicine Business (2016-2021)
.5 CordLife Recent Development
11.20 Integra LifeSciences
11.20.1 Integra LifeSciences Company Details
11.20.2 Integra LifeSciences Business Overview
11.20.3 Integra LifeSciences Regenerative Medicine Introduction
11.20.4 Integra LifeSciences Revenue in Regenerative Medicine Business (2016-2021)
11.20.5 Integra LifeSciences Recent Development
11.21 Nuvasive
11.21.1 Nuvasive Company Details
11.21.2 Nuvasive Business Overview
11.21.3 Nuvasive Regenerative Medicine Introduction
11.21.4 Nuvasive Revenue in Regenerative Medicine Business (2016-2021)
11.21.5 Nuvasive Recent Development
11.22 Cook Biotech
11.22.1 Cook Biotech Company Details
11.22.2 Cook Biotech Business Overview
11.22.3 Cook Biotech Regenerative Medicine Introduction
11.22.4 Cook Biotech Revenue in Regenerative Medicine Business (2016-2021)
11.22.5 Cook Biotech Recent Development
11.23 Japan Tissue Engineering
11.23.1 Japan Tissue Engineering Company Details
11.23.2 Japan Tissue Engineering Business Overview
11.23.3 Japan Tissue Engineering Regenerative Medicine Introduction
11.23.4 Japan Tissue Engineering Revenue in Regenerative Medicine Business (2016-2021)
11.23.5 Japan Tissue Engineering Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Tissue Engineering
Table 4. Key Players of Biomaterial
Table 5. Key Players of Other
Table 6. Global Regenerative Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Regenerative Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Regenerative Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Regenerative Medicine Market Share by Regions (2016-2021)
Table 10. Global Regenerative Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Regenerative Medicine Market Share by Regions (2022-2027)
Table 12. Regenerative Medicine Market Trends
Table 13. Regenerative Medicine Market Drivers
Table 14. Regenerative Medicine Market Challenges
Table 15. Regenerative Medicine Market Restraints
Table 16. Global Regenerative Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Regenerative Medicine Market Share by Players (2016-2021)
Table 18. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2020)
Table 19. Ranking of Global Top Regenerative Medicine Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Regenerative Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Regenerative Medicine Product Solution and Service
Table 23. Date of Enter into Regenerative Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Regenerative Medicine Revenue Market Share by Type (2016-2021)
Table 27. Global Regenerative Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Regenerative Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Regenerative Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Regenerative Medicine Revenue Market Share by Application (2016-2021)
Table 31. Global Regenerative Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Regenerative Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Regenerative Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Regenerative Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Regenerative Medicine Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Regenerative Medicine Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 63. J & J (DePuy Synthes) Company Details
Table 64. J & J (DePuy Synthes) Business Overview
Table 65. J & J (DePuy Synthes) Regenerative Medicine Product
Table 66. J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 67. J & J (DePuy Synthes) Recent Development
Table 68. Medtronic Company Details
Table 69. Medtronic Business Overview
Table 70. Medtronic Regenerative Medicine Product
Table 71. Medtronic Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 72. Medtronic Recent Development
Table 73. Zimmer Biomet Company Details
Table 74. Zimmer Biomet Business Overview
Table 75. Zimmer Biomet Regenerative Medicine Product
Table 76. Zimmer Biomet Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 77. Zimmer Biomet Recent Development
Table 78. Stryker Company Details
Table 79. Stryker Business Overview
Table 80. Stryker Regenerative Medicine Product
Table 81. Stryker Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 82. Stryker Recent Development
Table 83. Allergan(Acelity) Company Details
Table 84. Allergan(Acelity) Business Overview
Table 85. Allergan(Acelity) Regenerative Medicine Product
Table 86. Allergan(Acelity) Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 87. Allergan(Acelity) Recent Development
Table 88. MiMedx Group Company Details
Table 89. MiMedx Group Business Overview
Table 90. MiMedx Group Regenerative Medicine Product
Table 91. MiMedx Group Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 92. MiMedx Group Recent Development
Table 93. Organogenesis Company Details
Table 94. Organogenesis Business Overview
Table 95. Organogenesis Regenerative Medicine Product
Table 96. Organogenesis Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 97. Organogenesis Recent Development
Table 98. Fujifilm Cellular Dynamics Company Details
Table 99. Fujifilm Cellular Dynamics Business Overview
Table 100. Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 101. Fujifilm Cellular Dynamics Recent Development
Table 102. Osiris Therapeutics Company Details
Table 103. Osiris Therapeutics Business Overview
Table 104. Osiris Therapeutics Regenerative Medicine Product
Table 105. Osiris Therapeutics Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 106. Osiris Therapeutics Recent Development
Table 107. Vcanbio Company Details
Table 108. Vcanbio Business Overview
Table 109. Vcanbio Regenerative Medicine Product
Table 110. Vcanbio Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 111. Vcanbio Recent Development
Table 112. CCBC Company Details
Table 113. CCBC Business Overview
Table 114. CCBC Regenerative Medicine Product
Table 115. CCBC Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 116. CCBC Recent Development
Table 117. Cytori Company Details
Table 118. Cytori Business Overview
Table 119. Cytori Regenerative Medicine Product
Table 120. Cytori Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 121. Cytori Recent Development
Table 122. Celgene Company Details
Table 123. Celgene Business Overview
Table 124. Celgene Regenerative Medicine Product
Table 125. Celgene Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 126. Celgene Recent Development
Table 127. Vericel Corporation Company Details
Table 128. Vericel Corporation Business Overview
Table 129. Vericel Corporation Regenerative Medicine Product
Table 130. Vericel Corporation Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 131. Vericel Corporation Recent Development
Table 132. Guanhao Biotech Company Details
Table 133. Guanhao Biotech Business Overview
Table 134. Guanhao Biotech Regenerative Medicine Product
Table 135. Guanhao Biotech Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 136. Guanhao Biotech Recent Development
Table 137. Mesoblast Company Details
Table 138. Mesoblast Business Overview
Table 139. Mesoblast Regenerative Medicine Product
Table 140. Mesoblast Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 141. Mesoblast Recent Development
Table 142. AMAG Pharmaceuticals (CBR) Company Details
Table 143. AMAG Pharmaceuticals (CBR) Business Overview
Table 144. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product
Table 145. AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 146. AMAG Pharmaceuticals (CBR) Recent Development
Table 147. ViaCord Company Details
Table 148. ViaCord Business Overview
Table 149. ViaCord Regenerative Medicine Product
Table 150. ViaCord Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 151. ViaCord Recent Development
Table 152. CordLife Company Details
Table 153. CordLife Business Overview
Table 154. CordLife Regenerative Medicine Product
Table 155. CordLife Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 156. CordLife Recent Development
Table 157. Integra LifeSciences Company Details
Table 158. Integra LifeSciences Business Overview
Table 159. Integra LifeSciences Regenerative Medicine Product
Table 160. Integra LifeSciences Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 161. Integra LifeSciences Recent Development
Table 162. Nuvasive Company Details
Table 163. Nuvasive Business Overview
Table 164. Nuvasive Regenerative Medicine Product
Table 165. Nuvasive Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 166. Nuvasive Recent Development
Table 167. Cook Biotech Company Details
Table 168. Cook Biotech Business Overview
Table 169. Cook Biotech Regenerative Medicine Product
Table 170. Cook Biotech Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 171. Cook Biotech Recent Development
Table 172. Japan Tissue Engineering Company Details
Table 173. Japan Tissue Engineering Business Overview
Table 174. Japan Tissue Engineering Regenerative Medicine Product
Table 175. Japan Tissue Engineering Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million)
Table 176. Japan Tissue Engineering Recent Development
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Regenerative Medicine Market Share by Type: 2020 VS 2027
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Biomaterial Features
Figure 5. Other Features
Figure 6. Global Regenerative Medicine Market Share by Application: 2020 VS 2027
Figure 7. Dermatology Case Studies
Figure 8. Cardiovascular Case Studies
Figure 9. CNS Case Studies
Figure 10. Orthopedic Case Studies
Figure 11. Others Case Studies
Figure 12. Regenerative Medicine Report Years Considered
Figure 13. Global Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Regenerative Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Regenerative Medicine Market Share by Regions: 2020 VS 2027
Figure 16. Global Regenerative Medicine Market Share by Regions (2022-2027)
Figure 17. Global Regenerative Medicine Market Share by Players in 2020
Figure 18. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2020
Figure 20. Global Regenerative Medicine Revenue Market Share by Type (2016-2021)
Figure 21. Global Regenerative Medicine Revenue Market Share by Type (2022-2027)
Figure 22. North America Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Regenerative Medicine Market Share by Type (2016-2027)
Figure 24. North America Regenerative Medicine Market Share by Application (2016-2027)
Figure 25. North America Regenerative Medicine Market Share by Country (2016-2027)
Figure 26. United States Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Regenerative Medicine Market Share by Type (2016-2027)
Figure 30. Europe Regenerative Medicine Market Share by Application (2016-2027)
Figure 31. Europe Regenerative Medicine Market Share by Country (2016-2027)
Figure 32. Germany Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Regenerative Medicine Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Regenerative Medicine Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Regenerative Medicine Market Share by Region (2016-2027)
Figure 42. China Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Regenerative Medicine Market Share by Type (2016-2027)
Figure 50. Latin America Regenerative Medicine Market Share by Application (2016-2027)
Figure 51. Latin America Regenerative Medicine Market Share by Country (2016-2027)
Figure 52. Mexico Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Regen